MedTrace Logo

Effect of Ingesting a Tomato Pomace Extract on Platelet Aggregation

NCT02986165 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2018-08-28

No results posted yet for this study

Summary

This study evaluates the acute and longer term effects of a tomato pomace extract on platelet aggregation in health subjects.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo control

The placebo control is water containing a commercially available orange flavoured powder (Kool aid) which will be diluted according to the manufacturer's instructions

DIETARY_SUPPLEMENT

Low dose pomace extract

Immediately prior to ingestion, 'drinks' containing 1 g of tomato pomace extract will be prepared at the research facility. The water used to dilute the extract will be flavoured using a commercially available orange flavoured powder (Kool aid) which will be diluted according to the manufacturer's instructions before adding to the tomato pomace extract.

DIETARY_SUPPLEMENT

High dose pomace extract

Immediately prior to ingestion, 'drinks' containing 2.5 g of tomato pomace extract will be prepared at the research facility. The water used to dilute the extract will be flavoured using a commercially available orange flavoured powder (Kool aid) which will be diluted according to the manufacturer's instructions before adding to the tomato pomace extract.

Sponsors & Collaborators

  • University of Talca

    collaborator OTHER

  • Quadram Institute Bioscience

    collaborator OTHER

  • Centro de Estudios en Alimentos Procesados

    lead OTHER

Principal Investigators

  • Ivan Palomo, Dr. · University of Talca

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-07-31
Completion
2017-12-31

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02986165 on ClinicalTrials.gov